Clinical Trial Update: Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

This Phase 1 trial is evaluating the combination of venetoclax and bomedemstat in patients with relapsed or refractory acute myeloid leukemia; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Bomedemstat (bomedemstat)
• Venclexta (venetoclax)

Snippet

Sponsor: Terrence J Bradley, MD | Conditions: Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING